Nurulimab
Product Specifications
UNSPSC Description
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma[1].
Target Antigen
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nurulimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Nurulimab]
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 34, No. 1, 2020.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99760/Nurulimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99760/Nurulimab-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
2168561-20-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP1-72642 1 mg
Rabbit Polyclonal Rabbit anti-Sheep IgG Fc Secondary Antibody [Alkaline Phosphatase]
Ask
View Details MBS6464310-01 0.2 mL
ASPN, ID (Asporin, Periodontal Ligament-associated Protein 1, PLAP-1, SLRR1C, PLAP1, UNQ215/PRO241) (Biotin)
Ask
View Details MBS6464310-02 5x 0.2 mL
ASPN, ID (Asporin, Periodontal Ligament-associated Protein 1, PLAP-1, SLRR1C, PLAP1, UNQ215/PRO241) (Biotin)
Ask
View Details